2 days ago
BIOA
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Top 22%
#1143 out of 5213 analysts
Average Return
+6.5%
Win Rate
46%30 out of 65
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bioage Labs IncBIOA | +231.74% | $6.05 | $20.07 | 2025-10-21 - 2026-03-11 | Strong Buy |
Bioage Labs IncBIOA | +161.33% | $7.68 | $20.07 | 2025-10-28 - 2026-03-11 | Strong Buy |
Allogene Therapeutics IncALLO | +141.28% | $1.09 | $2.63 | 2025-05-14 - 2026-03-11 | Strong Buy |
Roivant Sciences LtdROIV | +138.74% | $12.39 | $29.58 | 2025-09-01 - 2026-03-11 | Strong Buy |
Structure Therapeutics IncGPCR | +114.84% | $27.09 | $58.20 | 2025-05-01 - 2026-03-11 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
9 days ago
CPRX
a month ago
ROIV
2 years ago
CABA
2 years ago
EDIT
2 years ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bioage Labs IncBIOA | 6 | Strong Buy | $52.00 | +159.09% | Maintains | 2 days ago |
Agios Pharmaceuticals IncAGIO | 2 | Strong Buy | $46.00 | +63.88% | Maintains | 7 days ago |
Catalyst Pharmaceuticals IncCPRX | 4 | Strong Buy | $35.00 | +43.41% | Maintains | 9 days ago |
Larimar Therapeutics IncLRMR | 7 | Strong Buy | $14.00 | +158.30% | Maintains | 15 days ago |
Cullinan Therapeutics IncCGEM | 1 | Strong Buy | $33.00 | +130.61% | Initiates Coverage On | 23 days ago |
Roivant Sciences LtdROIV | 4 | Strong Buy | $35.00 | +18.32% | Maintains | a month ago |
Argenx SeARGX | 8 | Strong Buy | $1,091.00 | +49.84% | Maintains | 2 months ago |
Amicus Therapeutics IncFOLD | 2 | Hold | $14.50 | +0.90% | Downgrades | 3 months ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $64.00 | +54.22% | Initiates Coverage On | 3 months ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $30.00 | +113.07% | Maintains | 3 months ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $100.00 | +71.82% | Maintains | 3 months ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $102.00 | +39.10% | Initiates Coverage On | 3 months ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $136.00 | +51.08% | Initiates Coverage On | 4 months ago |
Biohaven LtdBHVN | 2 | Strong Buy | $14.00 | +33.84% | Maintains | 4 months ago |
Prime Medicine IncPRME | 5 | Hold | $4.25 | +10.97% | Maintains | 4 months ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Sell | $5.00 | -71.97% | Downgrades | 4 months ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $10.00 | +205.81% | Maintains | 7 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $4.00 | +52.09% | Maintains | 10 months ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | N/A | Maintains | a year ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $80.00 | N/A | Reinstates | 2 years ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 3 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Strong Buy | $56.00 | N/A | Maintains | 3 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.